Trial of Nivolumab in Combination With Ipilimumab in Subjects With Previously Untreated Metastatic Uveal Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Bristol-Myers Squibb
Related studies linked through entity extraction aliases.
Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Patients
- Status
- RECRUITING
- Phase
- N/A
An Investigational Immuno-therapy Study of Nivolumab Compared to Temozolomide, Each Given With Radiation Therapy, for Newly-diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer)
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy Study of Nivolumab Compared to Docetaxel in Subjects Previously Treated With Advanced or Metastatic Non Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Elotuzumab in Combination With Pomalidomide and Low Dose Dexamethasone and Elotuzumab in Combination With Nivolumab in Patients With Multiple Myeloma Relapsed or Refractory to Prior Treatment With Lenalidomide.
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Tolerability Study of BMS-986177 in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
- Status
- COMPLETED
- Phase
- PHASE4
Biomarker-Driven Therapy With Nivolumab and Ipilimumab in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Expressing AR-V7
- Status
- COMPLETED
- Phase
- PHASE2
Survey on Long-Term Use of ORENCIA® Intravenous Infusion 250mg
- Status
- COMPLETED
- Phase
- N/A
Use-Results Survey for ORENCIA® Subcutaneous Injection 125mg Syringe 1mL
- Status
- COMPLETED
- Phase
- N/A
Lirilumab and Nivolumab With 5-Azacitidine in Patients With Myelodysplastic Syndromes (MDS)
- Status
- TERMINATED
- Phase
- PHASE2
Nivolumab Combined With Ipilimumab Followed by Nivolumab Monotherapy as First-Line Treatment for Patients With Advanced Melanoma
- Status
- COMPLETED
- Phase
- PHASE3
An Investigational Immuno-therapy Study of Experimental Medication BMS-986156, Given by Itself or in Combination With Nivolumab in Patients With Solid Cancers or Cancers That Have Spread.
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Patient-Reported Efficacy of Subcutaneous (SC) Abatacept in Rheumatoid Arthritis (RA) - South Africa
- Status
- COMPLETED
- Phase
- N/A
An Investigational Immuno-therapy Safety Trial of Nivolumab in Patients With Advanced or Metastatic Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE4
A Study of Safety, Tolerability and Pharmacokinetics of Nivolumab in Chinese Subjects With Previously Treated Advanced or Recurrent Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Pilot Study to Evaluate the Safety and Efficacy of Abatacept in Adults and Children 6 Years and Older With Excessive Loss of Protein in the Urine Due to Either Focal Segmental Glomerulosclerosis (FSGS) or Minimal Change Disease (MCD)
- Status
- COMPLETED
- Phase
- PHASE2
A Nationwide Registry Study of Patients With Nonvalvular Atrial Fibrillation Initiating Oral Anticoagulation Therapies In The Early Period Following Apixaban Marketing In Denmark
- Status
- COMPLETED
- Phase
- N/A
SSAT067 PK of Atazanavir/Cobicistat and Darunavir/Cobicistat
- Status
- COMPLETED
- Phase
- PHASE1
A Double-Blinded Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986020 Versus Placebo in Diffuse Cutaneous Systemic Sclerosis (dcSSc)
- Status
- WITHDRAWN
- Phase
- PHASE2